☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
86-1885237 |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
640 Fifth Avenue, 14th Floor New York, New York |
10019 |
|
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
||
Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant |
CCIXU |
The Nasdaq Stock Market LLC |
||
Class A ordinary shares, par value $0.0001 par value |
CCIX |
The Nasdaq Stock Market LLC |
||
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share |
CCIXW |
The Nasdaq Stock Market LLC |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
CHURCHILL CAPITAL CORP IX
FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2024
TABLE OF CONTENTS
i
June 30, 2024 |
December 31, 2023 |
|||||||
(Unaudited) | ||||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | 1,671,252 | $ | — | ||||
Prepaid expenses |
42,182 | — | ||||||
Short term prepaid insurance |
430,995 | |||||||
|
|
|
|
|||||
Total current assets |
2,144,429 | — | ||||||
Deferred offering costs |
— | 65,353 | ||||||
Long term prepaid insurance |
367,543 | — | ||||||
Marketable securities and cash held in Trust account |
289,760,889 | — | ||||||
|
|
|
|
|||||
Total Assets |
$ |
292,272,861 |
$ |
65,353 |
||||
|
|
|
|
|||||
Liabilities and Shareholders’ (Deficit) Equity: |
||||||||
Current liabilities: |
||||||||
Accrued expenses |
$ | 76,670 | $ | 18,958 | ||||
Accrued offering costs |
— | 2,853 | ||||||
Promissory note – related party |
— | 37,500 | ||||||
|
|
|
|
|||||
Total current liabilities |
76,670 | 59,311 | ||||||
Deferred underwriting fee payable |
10,062,500 | — | ||||||
|
|
|
|
|||||
Total Liabilities |
10,139,170 |
59,311 |
||||||
|
|
|
|
|||||
Commitments and Contingencies (Note 6) |
||||||||
Class A ordinary shares subject to possible redemption, 28,750,000 shares at redemption value of approximately $10.04 per share |
288,760,889 | — |
||||||
Shareholders’ (Deficit) Equity |
||||||||
Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of June 30, 2024 and December 31, 2023
|
— |
— | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 725,000 and none issued or outstanding as of June 30, 2024 and December 31, 2023, respectively (excluding 28,750,000 shares subject to possible redemption) |
73 | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,187,500 shares issued and outstanding as of June 30, 2024 and December 31, 2023
|
719 | 719 | ||||||
Additional paid-in capital |
— |
24,281 | ||||||
Accumulated deficit |
(6,627,990 | ) | (18,958 | ) | ||||
|
|
|
|
|||||
Total Shareholders’ (Deficit) Equity |
(6,627,198 |
) |
6,042 |
|||||
|
|
|
|
|||||
Total Liabilities and Shareholders’ (Deficit) Equity |
$ |
292,272,861 |
$ |
65,353 |
||||
|
|
|
|
Three Months Ended |
Six Months Ended |
|||||||
June 30, |
June 30, |
|||||||
2024 |
2024 |
|||||||
General and administrative expenses |
$ | 298,162 | $ | 322,254 | ||||
|
|
|
|
|||||
Loss from operations |
(298,162 |
) |
(322,254 |
) | ||||
|
|
|
|
|||||
Other income: |
||||||||
Interest income earned on Trust Account |
2,260,889 | 2,260,889 | ||||||
|
|
|
|
|||||
Total other income |
2,260,889 | 2,260,889 | ||||||
|
|
|
|
|
|
|
|
|
Net income |
$ |
1,962,727 |
$ |
1,938,635 |
||||
|
|
|
|
|||||
Basic and diluted weighted average Class A redeemable ordinary shares outstanding |
17,569,444 | 8,736,188 | ||||||
|
|
|
|
|||||
Basic and diluted net income per Class A redeemable ordinary share |
$ | 0.08 |
$ |
0.13 |
||||
|
|
|
|
|||||
Basic weighted average non-redeemable Class A and B ordinary shares outstanding |
7,265,972 | 6,755,180 | ||||||
|
|
|
|
|||||
Basic net income per non-redeemable Class A and B ordinary share |
$ |
0.08 |
$ |
0.13 |
||||
|
|
|
|
|||||
Diluted weighted average non-redeemable Class A and B ordinary shares outstanding |
7,630,556 |
6,936,464 |
||||||
|
|
|
|
|||||
Diluted net income per non-redeemable Class A and B ordinary share |
$ |
0.08 |
$ | 0.12 |
||||
|
|
|
|
Class A |
Class B |
Additional |
Total |
|||||||||||||||||||||||||
Ordinary Shares |
Ordinary Shares |
Paid-in |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
(Deficit) Equity |
||||||||||||||||||||||
Balance as of January 1, 2024 |
— | $ | — | 7,187,500 |
$ |
719 |
$ |
24,281 |
$ |
(18,958 |
) |
$ |
6,042 |
|||||||||||||||
Net loss |
— | — | — | — | — | (24,092 | ) | (24,092 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of March 31, 2024 |
— | $ | — | 7,187,500 |
$ |
719 |
$ |
24,281 |
$ |
(43,050 |
) |
$ |
(18,050 |
) | ||||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— | — | — | — | (8,625,265 | ) | (8,547,667 | ) | (17,172,932 | ) | ||||||||||||||||||
Sale of Private Placement Units |
725,000 | 73 | — | — | 7,249,927 | — | 7,250,000 | |||||||||||||||||||||
FV of Public Warrants at issuance |
— | — | — | — | 1,437,500 | — | 1,437,500 | |||||||||||||||||||||
Allocated value of transaction costs to Public Warrants and Private Units |
— | — | — | — | (86,443 | ) | — | (86,443 | ) | |||||||||||||||||||
Net income |
— | — | — | — | — | 1,962,727 | 1,962,727 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of June 30, 2024 |
725,000 |
$ |
73 |
7,187,500 |
$ |
719 |
$ |
— |
$ |
(6,627,990 |
) |
$ |
(6,627,198 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities: |
||||
Net income |
$ | 1,938,635 | ||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Formation and operating expenses paid by Sponsor |
44,020 | |||
Interest income earned on Trust Account |
(2,260,889 | ) | ||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
(42,182 | ) | ||
Prepaid insurance |
(798,538 | ) | ||
Accrued expenses |
57,711 | |||
|
|
|||
Net cash used in operating activities |
(1,061,243 |
) | ||
|
|
|||
Cash Flows from Investing Activities: |
||||
Investment of cash into Trust Account |
(287,500,000 | ) | ||
|
|
|||
Net cash used in investing activities |
(287,500,000 |
) | ||
|
|
|||
Cash Flows from Financing Activities: |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
281,750,000 | |||
Proceeds from sale of Private Placement Units |
7,250,000 | |||
Underwriters’ reimbursement |
1,808,750 | |||
Repayment of promissory note - related party |
(314,295 | ) | ||
Payment of offering costs |
(261,960 | ) | ||
|
|
|||
Net cash provided by financing activities |
290,232,495 |
|||
|
|
|||
Net Change in Cash |
1,671,252 |
|||
Cash – Beginning of period |
— | |||
|
|
|||
Cash – End of period |
$ |
1,671,252 |
||
|
|
|||
Non-Cash investing and financing activities: |
||||
|
|
|||
Deferred underwriting fee payable |
$ | 10,062,500 | ||
|
|
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2024 |
2024 |
|||||||||||||||
Class A Redeemable |
Class A and B Non-Redeemable
|
Class A Redeemable |
Class A and B Non-Redeemable
|
|||||||||||||
Basic net income per share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | 1,388,502 | $ | 574,225 | $ | 1,093,272 | $ | 845,363 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Denominator: |
||||||||||||||||
Weighted-average shares outstanding |
17,569,444 | 7,265,972 | 8,736,188 | 6,755,180 | ||||||||||||
Basic income per share |
$ | 0.08 | $ | 0.08 | $ | 0.13 | $ | 0.13 |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2024 |
2024 |
|||||||||||||||
Class A Redeemable |
Class A and B Non-Redeemable
|
Class A Redeemable |
Class A and B Non-Redeemable
|
|||||||||||||
Diluted net income per share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | 1,368,414 | $ | 594,313 | $ | 1,080,626 | $ | 858,009 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Denominator: |
||||||||||||||||
Weighted-average shares outstanding |
17,569,444 | 7,630,556 | 8,736,188 | 6,936,464 | ||||||||||||
Diluted income per share |
$ | 0.08 | $ | 0.08 | $ | 0.13 | $ | 0.12 |
Gross proceeds |
$ | 287,500,000 | ||
Less: |
||||
Proceeds allocated to Public Warrants |
(1,437,500 | ) | ||
Class A ordinary shares issuance costs |
(14,474,543 | ) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
17,172,932 | |||
|
|
|||
Class A ordinary shares subject to possible redemption, June 30, 2024 |
$ | 288,760,889 | ||
|
|
• | In whole and not in part; |
• | At a price of $ 0.01 per warrant; |
• | Upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”); and |
• | if, and only if, the last sale price of the Class A ordinary shares equals or exceeds $ 18.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout such 30 trading day period and the 30 -day |
June 30, 2024 |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||||||
Assets: |
||||||||||||||||
Marketable Securities and Cash Held in Trust Account |
$ |
289,760,889 |
$ |
289,760,889 |
$ |
— |
$ |
— |
May 6, 2024 |
||||
Market price of public shares |
$ | 9.76 | ||
Term (years) |
6.61 | |||
Risk-free rate |
4.43 | % | ||
Volatility |
5.0 | % | ||
Market Pricing Adjustment |
15.0 | % |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this Quarterly Report on Form 10-Q (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Churchill Capital Corp IX. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Churchill Sponsor IX LLC, an affiliate of M. Klein and Company, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in this Quarterly Report including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking statements. When used in this Quarterly Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto included in this Quarterly Report under “Item 1. Financial Statements”
Overview
We are a blank check company incorporated in the Cayman Islands on December 18, 2023, formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that we have not yet identified. We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Units, our shares, debt or a combination of cash, shares and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
On January 24, 2024, the SEC adopted new rules and regulations for special purpose acquisition companies (“SPACs”), which will become effective on July 1, 2024 (the “2024 SPAC Rules”). The 2024 SPAC Rules require, among other matters, (i) additional disclosures relating to SPAC Business Combination transactions; (ii) additional disclosures relating to dilution and to conflicts of interest involving sponsors and their affiliates in both SPAC initial public offerings and Business Combination transactions; (iii) additional disclosures regarding projections included in SEC filings in connection with proposed Business Combination transactions; and (iv) the requirement that both the SPAC and its target company be co-registrants for Business Combination registration statements. In addition, the SEC’s adopting release provided guidance describing circumstances in which a SPAC could become subject to regulation under the Investment Company Act, including its duration, asset composition, business purpose, and the activities of the SPAC and its management team in furtherance of such goals. The 2024 SPAC Rules may materially affect our ability to negotiate and complete our initial Business Combination and may increase the costs and time related thereto.
Recent Developments
On July 27, 2024, the Company’s board of directors (the “Board”) of appointed William Sherman as a director and as a member of the audit committee and the compensation committee of the Board, effective as of July 30, 2024.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from December 18, 2023 (inception) through June 30, 2024 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended June 30, 2024, we had net income of $1,962,727, which includes $2,260,889 of interest income earned on Trust Account, interest income earned on Trust, offset by $298,162 of general and administrative costs.
For the six months ended June 30, 2024, we had net income of $1,938,635, which includes $2,260,889 of interest income earned on Trust Account, interest income earned on Trust, offset by $322,254 of general and administrative costs.
Factors That May Adversely Affect our Results of Operations
Our results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. We cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial Business Combination.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor and loans from the Sponsor.
14
On May 6, 2024, we consummated the Initial Public Offering of 28,750,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,750,000 Units, at $10.00 per Unit, generating gross proceeds of $287,500,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 725,000 Private Placement Units to the Sponsor at a price of $10.00 per Unit, generating gross proceeds of $7,250,000.
Following the Initial Public Offering and the private placement, a total of $287,500,000 ($10.00 per Unit) was placed in the Trust Account. We incurred transaction costs of $14,560,986 consisting of $5,750,000 of upfront discount to the underwriters, $10,062,500 of deferred underwriting fees, and $557,236 of other offering costs, offset by reimbursement from the underwriters of $1,808,750.
We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less permitted withdrawals and deferred underwriting discounts and commissions), to complete our initial Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination, and to pay for directors and officers liability insurance premiums.
In order to finance working capital deficit or to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes its initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of the Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units and the underlying securities would be identical to the Private Placement Units.
In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” as of June 30, 2024, the Company has sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial statements. The Company cannot assure that its plans to consummate an Initial Business Combination will be successful.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2024. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
15
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an aggregate of $30,000 per month to the Sponsor or an affiliate thereof for office space, utilities, and secretarial and administrative support. We will begin incurring these fees on May 2, 2024 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation.
The underwriters are entitled to a deferred underwriting commission of 3.5% on the Units sold or $10,062,500 in the aggregate, of the gross proceeds of the Initial Public Offering held in the Trust Account upon the completion of our initial Business Combination subject to the terms of the underwriting commission.
Critical Accounting Estimates
The preparation of condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results could materially differ from those estimates. As of June 30, 2024 and December 31, 2023, we did not have any critical accounting estimates to be disclosed.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
16
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended June 30, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective at a reasonable assurance level and, accordingly, provided reasonable assurance that the information required to be disclosed by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter of 2024 covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
17
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Quarterly Report. For additional risks relating to our operations, see the section titled “Risk Factors” contained in our final prospectus for the Initial Public Offering filed with the SEC on May 3, 2024. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus for the Initial Public Offering filed with the SEC, except we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On May 6, 2024, we consummated the Initial Public Offering of 28,750,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,750,000 Units, at $10.00 per Unit, generating gross proceeds of $287,500,000. Each Unit consists of one Class A ordinary share, and one-quarter of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Each warrant will become exercisable 30 days after the completion of the initial Business Combination and will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation.
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 725,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement. Each Unit consists of one Public Share and one-quarter of one Private Warrant. Each Private Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per shares, subject to adjustments.
We incurred transaction costs amounting to $14,560,986 consisting of $5,750,000 of upfront discount to the underwriters, $10,062,500 of deferred underwriting fees, and $557,236 of other offering costs, offset by reimbursement from the underwriters of $1,808,750.
After deducting the underwriting fees (excluding the deferred portion of $10,062,500, which amount will be payable upon consummation of our initial Business Combination, if consummated) and the offering expenses, the total net proceeds from the Initial Public Offering and the Private Placement was $290,251,514 of which $287,500,000 was placed in the Trust Account.
For a description of the use of the proceeds generated in the Initial Public Offering, see Part I, Item 2 of this Quarterly Report.
Item 3. Defaults upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
None.
18
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
* | Filed herewith. |
** | Furnished herewith. |
19
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CHURCHILL CAPITAL CORP IX | ||||||
Date: August 13, 2024 | By: | /s/ Michael Klein |
||||
Name: | Michael Klein | |||||
Title: | Chief Executive Officer, President, and Chairman of the Board of Directors | |||||
(Principal Executive Officer) | ||||||
Date: August 13, 2024 | By: | /s/ Jay Taragin |
||||
Name: | Jay Taragin | |||||
Title: | Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |
20
EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Michael Klein, certify that:
1. | I have reviewed this quarterly report on Form 10-Q for the quarterly period ended June 30, 2024 of Churchill Capital Corp IX; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and |
b) | [Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313]; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: August 13, 2024
/s/ Michael Klein |
Michael Klein |
Chief Executive Officer, President, and Chairman of the Board of Directors |
(Principal Executive Officer) |
EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jay Taragin, certify that:
1. | I have reviewed this quarterly report on Form 10-Q for the quarterly period ended June 30, 2024 of Churchill Capital Corp IX; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and |
b) | [Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313]; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: August 13, 2024
/s/ Jay Taragin |
Jay Taragin |
Chief Financial Officer |
(Principal Financial and Accounting Officer) |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Churchill Capital Corp IX (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Michael Klein, Chief Executive Officer, President, and Chairman of the Board of Directors of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
1. | The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: August 13, 2024
/s/ Michael Klein |
Michael Klein |
Chief Executive Officer, President, and Chairman of the Board |
(Principal Executive Officer) |
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Churchill Capital Corp IX (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Jay Taragin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
1. | The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: August 13, 2024
/s/ Jay Taragin |
Jay Taragin |
Chief Financial Officer |
(Principal Financial and Accounting Officer) |